{
    "Trade/Device Name(s)": [
        "FLEX Monoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 1294, Ready-to-Use (Dako Omnis)",
        "Anti-Human PR, Clone PgR 1294 (Dako Omnis)"
    ],
    "Submitter Information": "Dako Denmark A/S",
    "510(k) Number": "K170005",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130861"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXZ"
    ],
    "Summary Letter Date": "December 28, 2017",
    "Summary Letter Received Date": "January 3, 2017",
    "Submission Date": "December 21, 2017",
    "Regulation Number(s)": [
        "21 CFR 864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry reagents and kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology",
        "immunology",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "Progesterone Receptor"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded tissue sections",
        "Human breast cancer tissue"
    ],
    "Specimen Container(s)": [
        "Dako Omnis Large Vial, 30mL"
    ],
    "Instrument(s)/Platform(s)": [
        "Dako Omnis",
        "EnVision FLEX visualization system"
    ],
    "Method(s)/Technology(ies)": [
        "Immunohistochemistry (IHC)"
    ],
    "Methodologies": [
        "Automated immunohistochemical slide staining"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Antibody"
    ],
    "Document Summary": "FDA 510(k) summary for FLEX Monoclonal Mouse Anti-Human Progesterone Receptor, Clone PgR 1294, Ready-to-Use (Dako Omnis) for qualitative detection of progesterone receptor in breast cancer tissue using immunohistochemistry on Dako Omnis.",
    "Indications for Use Summary": "Intended for use in immunohistochemistry with the EnVision FLEX visualization system and Dako Omnis instrument to qualitatively detect human progesterone receptor in formalin-fixed, paraffin-embedded tissue sections of human breast cancer, aiding in assessment of progesterone receptor status in breast carcinomas.",
    "fda_folder": "Hematology"
}